References - Homocysteine in Protein Structure/Function and Human Disease - page 138

140. Borowczyk K, Shih DM, Jakubowski H. Metabolism and neurotoxicity of homocysteine
thiolactone in mice: evidence for a protective role of paraoxonase 1. J Alzheimers Dis.
2012;30(2):225-31.
141. Borowczyk K, Tisonczyk J, Jakubowski H. Metabolism and neurotoxicity of homocysteine
thiolactone in mice: protective role of bleomycin hydrolase. Amino Acids. 2012;43
(3):1339-48.
142. Van Aerts LA, Klaasboer HH, Postma NS, Pertijs JC, Peereboom JH, Eskes TK, et al.
Stereospecific in vitro embryotoxicity of L-homocysteine in pre- and post-implantation
rodent embryos. Toxicol In Vitro. 1993;7(6):743-9.
143. Jakubowski H. The molecular basis of homocysteine thiolactone-mediated vascular disease.
Clin Chem Lab Med. 2007;45(12):1704-16.
144. Zinellu A, Sotgia S, Scanu B, Pintus G, Posadino AM, Cossu A, et al. S-homocysteinylated
LDL apolipoprotein B adversely affects human endothelial cells in vitro. Atherosclerosis.
2009;206(1):40-6.
145. Jacovina AT, Deora AB, Ling Q, Broekman MJ, Almeida D, Greenberg CB, et al. Homocys-
teine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinoly-
sis. J Clin Invest. 2009;119(11):3384-94.
146. Barbato JC, Catanescu O, Murray K, DiBello PM, Jacobsen DW. Targeting of
metallothionein by L-homocysteine: a novel mechanism for disruption of zinc and redox
homeostasis. Arterioscler Thromb Vasc Biol. 2007;27(1):49-54.
147. Harker LA, Ross R, Slichter SJ, Scott CR. Homocystine-induced arteriosclerosis. The role of
endothelial cell injury and platelet response in its genesis. J Clin Invest. 1976;58(3):731-41.
148. Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL,
Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease, vol. 1. 6th
ed. New York, NY: Mc Graw-Hill; 1995. p. 1279-327.
149. Endo N, Nishiyama K, Otsuka A, Kanouchi H, Taga M, Oka T. Antioxidant activity of
vitamin B6 delays homocysteine-induced atherosclerosis in rats. Br J Nutr. 2006;95
(6):1088-93.
150. Donahue S, Struman JA, Gaull G. Arteriosclerosis due to homocyst (e) inemia. Failure to
reproduce the model in weanling rabbits. Am J Pathol. 1974;77(2):167-74.
151. Makheja AN, Bombard AT, Randazzo RL, Bailey JM. Anti-inflammatory drugs in experi-
mental atherosclerosis. Part 3. Evaluation of the atherogenicity of homocystine in rabbits.
Atherosclerosis. 1978;29(1):105-12.
152. Jakubowski H, Ambrosius WT, Pratt JH. Genetic determinants of homocysteine
thiolactonase activity in humans: implications for atherosclerosis. FEBS Lett. 2001;491
(1-2):35-9.
153. Jakubowski H. Biosynthesis and reactions of homocysteine thiolactone. In: Jacobson D,
Carmel R, editors. Homocysteine in health and disease. Cambridge: Cambridge University
Press; 2001. p. 21-31.
154. Rosenquist TH, Ratashak SA, Selhub J. Homocysteine induces congenital defects of the heart
and neural tube: effect of folic acid. Proc Natl Acad Sci USA. 1996;93(26):15227-32.
155. Maestro de las Casas C, Epeldegui M, Tudela C, Varela-Moreiras G, Perez-Miguelsanz J.
High exogenous homocysteine modifies eye development in early chick embryos. Birth
Defects Res A Clin Mol Teratol. 2003;67(1):35-40.
156. Spence AM, Rasey JS, Dwyer-Hansen L, Grunbaum Z, Livesey J, Chin L, et al. Toxicity,
biodistribution and radioprotective capacity of L-homocysteine thiolactone in CNS tissues
and tumors in rodents: comparison with prior results with phosphorothioates. Radiother
Oncol. 1995;35(3):216-26.
157. Folbergrova J. Anticonvulsant action of both NMDA and non-NMDA receptor antagonists
against seizures induced by homocysteine in immature rats. Exp Neurol. 1997;145(2 Pt
1):442-50.
158. Langmeier M, Folbergrova J, Haugvicova R, Pokorny J, Mares P. Neuronal cell death in
hippocampus induced by homocysteic acid in immature rats. Epilepsia. 2003;44(3):299-304.